Valuation: Nephros, Inc.

Market Cap 46.81M 40.82M 38.54M 35M 65.57M 4.49B 65.84M 462M 178M 2.28B 176M 172M 7.35B P/E 2026 *
27.5x
P/E 2027 * 16.6x
Enterprise Value 46.81M 40.82M 38.54M 35M 65.57M 4.49B 65.84M 462M 178M 2.28B 176M 172M 7.35B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.82x
Free-Float
87.11%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 51 05/05/2023
Director of Finance/CFO 60 01/11/2023
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 19/09/2007
Director/Board Member 54 10/08/2018
Director/Board Member 58 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-1.69% - - 46.81M
+1.22%-4.76% - - 12.05B
+0.45%-3.15%+5.75%+39.94% 10.02B
-1.91%-11.31%+35.84%+328.36% 4.07B
+3.03%+2.86%+2.27%+209.10% 3.63B
+0.48%+0.48% - - 1.39B
+5.46%+9.61%+22.86%+91.27% 1.34B
+8.22%+0.35%+216.62%+232.42% 923M
+3.96%+2.81%+135.20%+131.43% 902M
+1.41%-0.89%+128.82%+154.68% 837M
Average +2.23%-0.27%+78.19%+169.60% 3.91B
Weighted average by Cap. +1.22%-3.08%+30.93%+141.81%

Financials

2026 *2027 *
Net sales 22.14M 19.3M 18.23M 16.55M 31.01M 2.12B 31.14M 218M 84.25M 1.08B 83.15M 81.31M 3.47B 25.66M 22.37M 21.12M 19.18M 35.94M 2.46B 36.09M 253M 97.64M 1.25B 96.37M 94.24M 4.03B
Net income 1.76M 1.54M 1.45M 1.32M 2.47M 169M 2.48M 17.4M 6.72M 86.07M 6.63M 6.48M 277M 2.92M 2.54M 2.4M 2.18M 4.08M 280M 4.1M 28.76M 11.1M 142M 10.95M 10.71M 458M
Net Debt - -
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!